Cullinan Therapeutics CGEM
NASDAQ CGEM
$22.17 +0.01 (+0.05%)
As of: Sep 4, 2026 · 2:30 PM EDT

Cullinan Therapeutics (CGEM) Dividend Coverage Ratio (2024)

Analysis

Cullinan Therapeutics (CGEM) Dividend Coverage Ratio (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Div. Cover (Qtr)
1 Vertex Pharmaceuticals 138.78 Bn 130.92 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.50 Bn 77.51 Bn 3.93 Bn 13.40
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn -
4 Moderna 58.06 Bn 52.92 Bn 52.00 Mn -
5 Revolution Medicines 44.04 Bn 44.04 Bn - -
6 BeOne Medicines 40.04 Bn 34.94 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn -
8 Royalty Pharma 28.41 Bn 27.57 Bn - 2.36
9 Insmed 27.42 Bn 26.26 Bn 358.27 Mn -
10 Cullinan Therapeutics 1.37 Bn 1.37 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 -61.69
Jun 30, 2024 -11.06